Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
AYTU BIOPHARMA, INC.
The company released its quarterly or annual results. An 8-K is the notice a US public company must file within four business days of a major event.
aytubio.comAI Executive Summary
AI-powered analysis of 8-K filing content
Aytu BioPharma announced its fiscal 2026 fourth quarter operational and financial results on September 22, 2026, via press release and public conference call, providing transparency on company performance and strategic initiatives.
Key Takeaways
Company released Q4 fiscal 2026 results demonstrating operational and financial performance for the latest quarter
Public conference call scheduled for 4:30 p.m. Eastern time on the same day to discuss results and address shareholder inquiries
1 more takeaway
Filing Overview
What This Means
AYTU BIOPHARMA, INC. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.